Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
about
Pseudovirions as vehicles for the delivery of siRNAPersistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infectionHuman dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy.Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Replication-Competent Controlled Herpes Simplex Virus.HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in miceHSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime.HSV-1-based amplicon vectors: design and applications.Use of viral vectors for the development of vaccines.HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.Genetic engineering of a modified herpes simplex virus 1 vaccine vector.HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.HSV Recombinant Vectors for Gene Therapy.Pre-existing immunity against vaccine vectors--friend or foe?A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.Herpes Virus Amplicon Vectors.Novel Concepts for HIV Vaccine Vector Design.
P2860
Q24634231-45AE9354-01A6-4FF9-BB24-724F493DE191Q24806094-5B9A6D65-8A09-4E66-B5AC-52CF0E8BBCC9Q33782430-6BE23F45-8923-4AF5-866F-DD4971EC9F16Q34433569-08779018-E93C-414F-8B40-88F4E4BCAFF2Q35131218-791BDBCC-225F-458E-BBAD-457E168915C1Q35199270-6F99ABD0-3AD6-4CD6-AC1E-269B12EF9456Q35750430-E967F31F-E5DF-4E97-B68D-412BE140D56BQ35865547-7330AFB7-5AA6-4F4B-81AC-E82CD6826C2AQ35868091-82FDBFFD-13B5-451B-B296-7153B92C4FF5Q36086213-46305860-FC2F-4B75-AB0C-4A060959992AQ36156347-D3879FB6-2DB9-49BA-B0C6-A293EC88E58AQ36166161-756547C8-6DFA-4385-BBDA-5F81DA7DF24AQ36288901-C3F1F5CE-0B05-42A2-B5E5-752C345850B1Q36780156-D7263C5D-614A-44D9-A722-8886E5DB104FQ36897379-77CA43B7-CAB7-41B3-95DE-28ED93F10702Q37188682-8A14C060-2899-430E-BE02-85245530C417Q37528088-EDCEDC36-ED8D-4AED-8B20-909021F0AD0DQ37787777-501F019F-A189-4D08-9403-A52235675553Q38061876-50C2B148-C42D-4329-BD9F-ABDC8D7EC4A4Q38353693-DEB9F00B-8DEB-42B6-AE99-5E0346CB614BQ39923388-D95AFF9E-CA0F-4B3B-8498-F6FD87D423F8Q47112156-C29D57C8-9A85-42CC-9CBE-FDE8005F800C
P2860
Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of human immunodefi ...... and humoral immune responses.
@ast
Expression of human immunodefi ...... and humoral immune responses.
@en
Expression of human immunodefi ...... and humoral immune responses.
@nl
type
label
Expression of human immunodefi ...... and humoral immune responses.
@ast
Expression of human immunodefi ...... and humoral immune responses.
@en
Expression of human immunodefi ...... and humoral immune responses.
@nl
prefLabel
Expression of human immunodefi ...... and humoral immune responses.
@ast
Expression of human immunodefi ...... and humoral immune responses.
@en
Expression of human immunodefi ...... and humoral immune responses.
@nl
P2093
P2860
P1433
P1476
Expression of human immunodefi ...... and humoral immune responses.
@en
P2093
Howard J Federoff
Peter K Hocknell
Rebecca D Wiley
Thomas G Evans
Tomas Hanke
William J Bowers
Xiuqing Wang
P2860
P304
P356
10.1128/JVI.76.11.5565-5580.2002
P407
P577
2002-06-01T00:00:00Z